Vaccines Updated During December 2022, From Oldest to Newest

Trumenba (Meningococcal Group B Vaccine)

Trumenba is indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. Trumenba is approved for use in individuals 10 through 25 years of…

Wyeth Pharmaceutical Division of Wyeth Holdings LLC2 December 2022

IXIARO (Japanese Encephalitis Vaccine, Inactivated, Adsorbed)

IXIARO is a vaccine indicated for the prevention of disease caused by Japanese encephalitis virus (JEV). IXIARO is approved for use in individuals 2 months of age and older. IXIARO is a…

Valneva Scotland Ltd.5 December 2022

Vaxchora (Cholera Vaccine, Live, Oral)

VAXCHORA is a vaccine indicated for active immunization against disease caused by Vibrio cholerae serogroup O1 in persons 2 through 64 years of age traveling to cholera-affected areas…

Emergent Travel Health Inc.14 December 2022

PREHEVBRIO (Hepatitis B Vaccine (Recombinant))

PREHEVBRIO is indicated for prevention of infection caused by all known subtypes of hepatitis B virus. PREHEVBRIO is approved for use in adults 18 years of age and older. PREHEVBRIO is…

VBI Vaccines (Delaware) Inc.30 December 2022

Vx Labels

Vaccine Sections

Vaccine Information by RSS

About

As the leading independent provider of trustworthy vaccine information, our database comes directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. VxLabels.com provides the full vaccine subset of the FDA's repository. Vaccine information provided here is not intended as a substitute for direct consultation with a qualified health professional.